Pediatrix Medical Group, Inc. (MD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5B 3B 4.5B Q4 '17: 3.5B Q1 '18: 3.5B Q2 '18: 3.5B Q3 '18: 3.5B Q4 '18: 3.5B Q1 '19: 3.5B Q2 '19: 3.1B Q3 '19: 2.8B Q4 '19: 2.3B Q1 '20: 1.9B Q2 '20: 1.8B Q3 '20: 1.8B Q4 '20: 1.7B Q1 '21: 1.7B Q2 '21: 1.8B Q3 '21: 1.8B Q4 '21: 1.9B Q1 '22: 1.9B Q2 '22: 2B Q3 '22: 2B Q4 '22: 2B Q1 '23: 2B Q2 '23: 2B Q3 '23: 2B Q4 '23: 2B Q1 '24: 2B Q2 '24: 2B Q3 '24: 2B Q4 '24: 2B Q1 '25: 2B Q2 '25: 1.9B Q3 '25: 1.9B Q4 '25: 1.9B Q1 '26: 1.9B Q2 '26: 2B Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-200M 0 200M 400M 600M Q4 '09: 288.9M Q1 '10: 295.9M Q2 '10: 303.2M Q3 '10: 306.2M Q4 '10: 312.9M Q1 '11: 325.1M Q2 '11: 336.1M Q3 '11: 349.8M Q4 '11: 355.4M Q1 '12: 359.1M Q4 '12: 389.5M Q1 '13: 401.7M Q2 '13: 415.3M Q3 '13: 431.2M Q4 '13: 452.1M Q1 '14: 464.7M Q2 '14: 481M Q3 '14: 495.8M Q4 '14: 513M Q1 '15: 523.7M Q2 '15: 535M Q3 '15: 548M Q4 '15: 557.9M Q1 '16: 567.3M Q2 '16: 574.1M Q3 '16: 579.9M Q4 '16: 571.7M Q1 '17: 553.5M Q2 '17: 527.6M Q3 '17: 497.2M Q4 '17: 480.1M Q1 '18: 473.7M Q2 '18: 474.2M Q3 '18: 452M Q4 '18: 431.8M Q1 '19: 410.6M Q2 '19: 347.6M Q3 '19: 292M Q4 '19: 226.6M Q1 '20: 158.9M Q2 '20: 134.1M Q3 '20: 106M Q4 '20: 98.1M Q1 '21: 113.4M Q2 '21: 128.9M Q3 '21: 167.2M Q4 '21: 202.9M Q1 '22: 215.9M Q2 '22: 216.1M Q3 '22: 204.7M Q4 '22: 172.7M Q1 '23: 163.6M Q2 '23: 162M Q3 '23: 154.8M Q4 '24: -68.7M Q1 '25: -52.5M Q2 '25: 165.1M Q3 '25: 199.3M Q4 '25: 208.8M Q1 '26: 218.4M Q2 '26: 215.4M Q4 '10 Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '26

Net Income TTM

-2.1B -1.4B -700M 0 700M 1.4B 2.1B Q4 '09: 175.8M Q1 '10: 180M Q2 '10: 186.2M Q3 '10: 199.3M Q4 '10: 202.7M Q1 '11: 209.9M Q2 '11: 216.5M Q3 '11: 213.4M Q4 '11: 218M Q1 '12: 220.9M Q4 '12: 240.9M Q1 '13: 247.9M Q2 '13: 256.6M Q3 '13: 267.6M Q4 '13: 280.5M Q1 '14: 288.8M Q2 '14: 298.6M Q3 '14: 307.9M Q4 '14: 317.3M Q1 '15: 322.3M Q2 '15: 327.4M Q3 '15: 332M Q4 '15: 336.3M Q1 '16: 335.5M Q2 '16: 333.8M Q3 '16: 339.5M Q4 '16: 324.9M Q1 '17: 311.7M Q2 '17: 293M Q3 '17: 262.3M Q4 '17: 320.4M Q1 '18: 329.1M Q2 '18: 344.8M Q3 '18: 344.5M Q4 '18: 268.6M Q1 '19: -37.7M Q2 '19: -125.3M Q3 '19: -1.4B Q4 '19: -1.5B Q1 '20: -1.3B Q2 '20: -1.9B Q3 '20: -722.9M Q4 '20: -796.5M Q1 '21: -760.1M Q2 '21: -52.7M Q3 '21: 19.2M Q4 '21: 131M Q1 '22: 92.1M Q2 '22: 84.3M Q3 '22: 84.2M Q4 '22: 66.3M Q1 '23: 101.7M Q2 '23: 102.9M Q3 '23: 93.5M Q4 '24: -99.1M Q1 '25: -82.4M Q2 '25: 109.9M Q3 '25: 162.2M Q4 '25: 165.4M Q1 '26: 174.2M Q2 '26: 174.8M Q4 '10 Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 200M 400M 600M Q2 '10: 229.7M Q3 '10: 228.4M Q4 '10: 240.6M Q1 '11: 267.7M Q2 '11: 271.3M Q3 '11: 266M Q4 '11: 270.7M Q1 '12: 253M Q4 '12: 324.9M Q1 '13: 338.6M Q2 '13: 348.7M Q3 '13: 371.9M Q4 '13: 405.4M Q1 '14: 374M Q2 '14: 381M Q3 '14: 382.5M Q4 '14: 422.6M Q1 '15: 418.8M Q2 '15: 430.7M Q3 '15: 443.4M Q4 '15: 368.7M Q1 '16: 389.3M Q2 '16: 393M Q3 '16: 417M Q4 '16: 443.8M Q1 '17: 455.1M Q2 '17: 442.9M Q3 '17: 446.7M Q4 '17: 511.4M Q1 '18: 419.5M Q2 '18: 417.2M Q3 '18: 358M Q4 '18: 313.7M Q1 '19: 370.5M Q2 '19: 355.3M Q3 '19: 373.8M Q4 '19: 357.7M Q1 '20: 272.6M Q2 '20: 341M Q3 '20: 351.8M Q4 '20: 298.7M Q1 '21: 358.4M Q2 '21: 223.6M Q3 '21: 114.7M Q4 '21: 107.5M Q1 '22: 92.2M Q2 '22: 121.1M Q3 '22: 143.3M Q4 '22: 166.9M Q1 '23: 163.5M Q2 '23: 170.2M Q3 '23: 166.8M Q4 '23: 137.3M Q1 '24: 113M Q2 '24: 130.9M Q3 '24: 142.8M Q4 '24: 206.6M Q1 '25: 214.3M Q2 '25: 244.6M Q3 '25: 290M Q4 '25: 271.1M Q1 '26: 258.7M Q2 '26: 246.9M Q4 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

0 150M 300M 450M Q2 '10: 215.6M Q3 '10: 214.3M Q4 '10: 228.4M Q1 '11: 239.4M Q2 '11: 243M Q3 '11: 235.3M Q4 '11: 239.3M Q1 '12: 239M Q4 '12: 310.4M Q1 '13: 322.7M Q2 '13: 331.7M Q3 '13: 354.7M Q4 '13: 389.7M Q1 '14: 358.1M Q2 '14: 366.9M Q3 '14: 368.1M Q4 '14: 404.6M Q1 '15: 399.9M Q2 '15: 407.7M Q3 '15: 416.8M Q4 '15: 341.6M Q1 '16: 357.2M Q2 '16: 359.4M Q3 '16: 381.4M Q4 '16: 404.5M Q1 '17: 414.5M Q2 '17: 400.9M Q3 '17: 403.9M Q4 '19: 338.4M Q1 '20: 249.4M Q2 '20: 320.8M Q3 '20: 325.6M Q4 '20: 269.9M Q1 '21: 330.4M Q2 '21: 193.1M Q3 '21: 78.7M Q4 '21: 75.3M Q1 '22: 61.9M Q2 '22: 93.7M Q3 '22: 119.5M Q4 '22: 137.2M Q1 '23: 133.9M Q2 '23: 139M Q3 '23: 133.4M Q4 '23: 104M Q1 '24: 81.4M Q2 '24: 100.4M Q3 '24: 115.2M Q4 '24: 184.6M Q1 '25: 194.3M Q2 '25: 227M Q3 '25: 273.4M Q4 '25: 252.6M Q1 '26: 237.3M Q2 '26: 228.6M Q3 '11 Q4 '13 Q3 '15 Q2 '17 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q2 '09: 46.3M Q3 '09: 46.7M Q1 '10: 47.3M Q2 '10: 1M Q3 '10: 47.5M Q4 '10: 48M Q1 '11: 48.4M Q2 '11: 48.7M Q3 '11: 48.9M Q4 '11: 49.1M Q1 '12: 49.4M Q1 '12: 49.4M Q2 '12: 49.5M Q3 '12: 49.8M Q4 '12: 100.2M Q1 '13: 100.8M Q2 '13: 101.1M Q3 '13: 101.2M Q4 '13: 101.1M Q1 '14: 100.7M Q2 '14: 99.9M Q3 '14: 100.1M Q4 '14: 99.1M Q1 '15: 95.3M Q2 '15: 93.5M Q3 '15: 93.6M Q4 '15: 93.5M Q1 '16: 93.1M Q2 '16: 92.9M Q3 '16: 93.1M Q4 '16: 93.3M Q1 '17: 93.1M Q2 '17: 92.8M Q3 '17: 92.9M Q4 '17: 93.2M Q1 '18: 93.5M Q2 '18: 93.5M Q3 '18: 91.4M Q4 '18: 88.3M Q1 '19: 86.5M Q2 '19: 83.7M Q3 '19: 82.9M Q4 '19: 83.3M Q1 '20: 82.8M Q2 '20: 83.7M Q3 '20: 83.9M Q4 '20: 85.1M Q1 '21: 85.5M Q2 '21: 85.9M Q3 '21: 86.1M Q1 '22: 85.4M Q2 '22: 85.6M Q3 '22: 82.8M Q1 '23: 82.3M Q2 '23: 82.7M Q3 '23: 83M Q1 '24: 83.3M Q2 '24: 83.3M Q3 '24: 84.5M Q1 '25: 85.4M Q2 '25: 85.5M Q3 '25: 85.6M Q1 '26: 83.1M Q2 '26: 81.4M Q2 '11 Q1 '13 Q1 '15 Q1 '17 Q1 '19 Q1 '21 Q3 '23 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-24.00 -16.00 -8.00 0.00 8.00 16.00 24.00 Q2 '11: 4.50 Q3 '11: 4.40 Q4 '11: 4.47 Q1 '12: 4.51 Q4 '12: 4.18 Q1 '13: 3.75 Q2 '13: 3.21 Q3 '13: 2.65 Q4 '13: 2.77 Q1 '14: 2.85 Q2 '14: 2.96 Q3 '14: 3.06 Q4 '14: 3.17 Q1 '15: 3.26 Q2 '15: 3.37 Q3 '15: 3.48 Q4 '15: 3.58 Q1 '16: 3.59 Q2 '16: 3.58 Q3 '16: 3.65 Q4 '16: 3.50 Q1 '17: 3.36 Q2 '17: 3.16 Q3 '17: 2.83 Q4 '17: 3.45 Q1 '18: 3.54 Q2 '18: 3.70 Q3 '18: 3.71 Q4 '18: 2.93 Q1 '19: -0.56 Q2 '19: -1.51 Q3 '19: -17.38 Q4 '19: -17.95 Q1 '20: -15.36 Q2 '20: -23.29 Q3 '20: -8.63 Q4 '20: -9.50 Q1 '21: -9.07 Q2 '21: -0.63 Q3 '21: 0.22 Q4 '21: 1.54 Q1 '22: 1.08 Q2 '22: 0.99 Q3 '22: 1.00 Q4 '22: 0.80 Q1 '23: 1.22 Q2 '23: 1.24 Q3 '23: 1.13 Q4 '24: -1.19 Q1 '25: -1.00 Q2 '25: 1.30 Q3 '25: 1.91 Q4 '25: 1.94 Q1 '26: 2.06 Q2 '26: 2.09 Q1 '13 Q4 '14 Q3 '16 Q2 '18 Q1 '20 Q4 '21 Q3 '23 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.